Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts Details-
Title Grant Type Focus Area Country Application Due Date Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2Release Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized AdultsRelease Date:Research Vaccines Italy Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult PopulationsRelease Date:Quality Improvement Vaccines Italy 2026 VAC US SMFM Maternal RSV QIRelease Date:Partner: Society for Maternal Fetal MedicineQuality Improvement Vaccines USA Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting ProfessorshipRelease Date:Partner: Prostate Cancer FoundationEducation Oncology USA New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)Release Date:Education Oncology All Closing Knowledge Gaps and Building Practical Skills in HRRm Testing for Metastatic Prostate CancerRelease Date:Education Oncology All Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast CancerRelease Date:Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophiliaRelease Date:Quality Improvement Inflammation & Immunology Australia, Chile, India, Italy, Spain, United Kingdom Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease RegistryRelease Date:Research Inflammation & Immunology Germany Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia InfectionsRelease Date:Research Inflammation & Immunology China Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China -
Title Grant Type Focus Area Country Application Due Date Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory ConditionsRelease Date:Improving the Clinical Management of Uncontrolled AcromegalyRelease Date:Antimicrobial Stewardship in the Asia-Pacific RegionRelease Date:Lysosomal Storage Disorders Fellowship for Nurse PractitionersRelease Date:Hemophilia PUP RegistryRelease Date:Quality Improvement Initiatives:Improving Screening and Diagnosis of Atrial Fibrillation and Optimizing Treatment and ManagementRelease Date:Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory ConditionsRelease Date:Accelerating the Detection, Diagnosis and Initial Treatment of Psoriatic ArthritisRelease Date:Improving the Identification and Management of Patients with Atrial Fibrillation (AF) and venous thromboembolism (VTE)Release Date:Medication Optimization in Primary CareRelease Date:Quality Improvement Activities to Prevent Fatal Pulmonary ThromboembolismRelease Date:Increasing Rates of BRCA Testing in Patients with Breast CancerRelease Date:Providing Access to Learning Resources for Nurses in AfricaRelease Date:Increasing Adult Pneumococcal Immunization Rates through AAFP State ChaptersRelease Date:Improving Vaccine Utilization and Preventive Health Maintenance in IBDRelease Date:Supporting Educational Programs for Radical Reform of Pain Treatment in JapanRelease Date:Improving Pediatric Immunization Care – Innovative Strategies to Improve Childhood Immunization RatesRelease Date:Rheumatology Nurse Practitioner and Physician Assistant FellowshipRelease Date:Cardiac Amyloidosis FellowshipRelease Date:Improving Pneumococcal Immunization of Adults with Immunocompromising ConditionsRelease Date:Efforts for Early Detection of Atrial Fibrillation and Prevention of Cardio Embolic StrokeRelease Date:Quality Improvement Activities to Prevent Fatal Pulmonary ThromboembolismRelease Date:Project CHANGE - Clinical practice oriented cHange solutions towards Active aNd healthy aGEingRelease Date:QI Initiaitives Focused on Undiagnosed Nonvalvular Atrial Fibrillation (NVAF)Release Date:Quality Improvement initiatives optimizing AF and VTE management in CanadaRelease Date:Improving the Management of Patients with Uncontrolled Acromegaly (International Developed Markets)Release Date:Pfizer and the National Kidney Foundation: Improving Immunization Rates of Patients with Chronic Kidney Disease Including DialysRelease Date:Education Hospital Albania Integrated Approach to Breast Health EquityRelease Date:Patient Registries In Metastatic Breast CancerRelease Date:Improving Patient Care in Tobacco DependencyRelease Date:Antimicrobial Stewardship in the Latin America RegionRelease Date:Management of Atopic Dermatitis – International Developed MarketsRelease Date:Improving Standard of Care for Chronic ADRelease Date:NCCN and Pfizer: Enhancing Academic-Community-Patient Partnerships in Metastatic Breast Cancer CareRelease Date:Translating the Atopic Dermatitis (AD)Release Date:UK Oncology Quality Improvement GrantsRelease Date:Treatment Patterns of CDK 4/6 Inhibitor Utilization in HR+/HER2- Metastatic Breast CancerRelease Date:Quality Improvement Grants to Support Development of Cardiac Amyloid CentersRelease Date:Vaccines for All: Longevity Unleashed for Everyone (VALUE)Release Date:Quality Improvement Vaccines Japan Breast Cancer Competitive Research Grant Program for Africa, the Middle East, Asia and Latin America RegionsRelease Date:Research Oncology All Bristol-Myers Squibb/Pfizer Alliance Announce Quality Improvement initiatives optimizing AF and VTE management in CanadaQuality Improvement Internal Medicine Canada Quality Improvement Grants to Support Development of Cardiac Amyloid CentersRelease Date:Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease USA Local Level Educational Grants Program to Increase Awareness and Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease USA Transthyretin Amyloid Cardiomyopathy (ATTR-CM) ResearchRelease Date:Research Rare Disease USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Fellowship Rare Disease USA Addressing Knowledge Gaps for the Appropriate Use of BiosimilarsRelease Date:Education Oncology Japan Acromegaly/Growth Hormone Excess ResearchRelease Date:Research Rare Disease USA